Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38.5M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
920K
-
Shares change
-
+52.6K
-
Total reported value, excl. options
-
$823K
-
Value change
-
+$43.2K
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$0.89
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q4 2019
10 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q4 2019.
Co-Diagnostics, Inc. - Common Stock (CODX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 920K shares
of 38.5M outstanding shares and own 2.39% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (591K shares), HighTower Advisors, LLC (132K shares), BARCLAYS PLC (86.8K shares), GEODE CAPITAL MANAGEMENT, LLC (48.3K shares), Virtu Financial LLC (37.5K shares), RENAISSANCE TECHNOLOGIES LLC (16K shares), DEUTSCHE BANK AG\ (5.35K shares), Advisor Group, Inc. (3K shares), VICTORY CAPITAL MANAGEMENT INC (0 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.